
TY  - JOUR
TI  - POSTERS
JO  - Diabetic Medicine
VL  - 23
IS  - s2
SN  - 0742-3071
UR  - https://doi.org/10.1111/j.1466-5468.2006.01875.x
DO  - doi:10.1111/j.1466-5468.2006.01875.x
SP  - 31
EP  - 138
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Oral Pathology & Medicine
JA  - J Oral Pathol Med
VL  - 48
IS  - S1
SN  - 0904-2512
UR  - https://doi.org/10.1111/jop.12796
DO  - doi:10.1111/jop.12796
SP  - 5
EP  - 83
PY  - 2019
ER  - 

TY  - JOUR
AU  - Cowan, Logan T.
AU  - Lakshminarayan, Kamakshi
AU  - Lutsey, Pamela L.
AU  - Folsom, Aaron R.
AU  - Beck, James
AU  - Offenbacher, Steven
AU  - Pankow, James S.
TI  - Periodontal disease and incident venous thromboembolism: The Atherosclerosis Risk in Communities study
JO  - Journal of Clinical Periodontology
JA  - J Clin Periodontol
VL  - 46
IS  - 1
SN  - 0303-6979
UR  - https://doi.org/10.1111/jcpe.13029
DO  - doi:10.1111/jcpe.13029
SP  - 12
EP  - 19
PY  - 2019
AB  - Abstract Aim Periodontal disease is a cardiovascular disease (CVD) risk factor but few studies have considered the relationship between periodontal disease and venous thromboembolism (VTE). We hypothesized that periodontal disease is independently associated with increased risk of incident VTE. Materials and methods We used data from 8,092 participants of the Atherosclerosis Risk in Communities (ARIC) study to examine periodontal disease in 1996?1998 and incident VTE through 2011. Periodontal disease was determined using self-reported tooth loss due to gum disease and dental examinations. Cox proportional hazards regression models were used to estimate hazard ratios for VTE and 95% confidence intervals adjusted for relevant confounders. Results and conclusions Participants were on average 62.7 years old at baseline and 13.9% self-reported tooth loss from gum disease. Over a mean of 12.9 years of follow-up, there were 313 incident VTE events. Self-reported tooth loss due to gum disease was associated with 30% higher VTE risk (HR = 1.29 (0.96, 1.73) after adjusting demographic factors, SES, periodontal risk factors, oral hygiene, and access to dental care variables. No statistically significant associations between clinical measures of periodontitis and VTE were observed after adjustment. Further research is needed to elucidate whether a relationship between periodontal disease and VTE exists.
ER  - 

TY  - JOUR
TI  - Poster Session 2: Abstracts
JO  - International Journal of Stroke
VL  - 1
IS  - s1
SN  - 1747-4930
UR  - https://doi.org/10.1111/j.1747-4949.2006.00073.x
DO  - doi:10.1111/j.1747-4949.2006.00073.x
SP  - 111
EP  - 174
PY  - 2006
ER  - 

C7  - pp. 42-89
TI  - Monitoring
SN  - 9781405153638
UR  - https://doi.org/10.1002/9780470692288.ch3
DO  - doi:10.1002/9780470692288.ch3
SP  - 42-89
KW  - cardiopulmonary function
KW  - anesthetics
KW  - carbon dioxide
KW  - dysrhyhmias
KW  - femoral artery
PY  - 2006
AB  - Summary This chapter contains section titled: Standard American Society of Anesthesiologists (ASA) monitors Advanced electrocardiographic (ECG) monitoring Arterial pressure monitoring Central venous access Central circulation pressure monitoring Transesophageal echocardiography Suggested reading
ER  - 

TY  - JOUR
TI  - 30th Annual Meeting of the Wound Healing Society SAWC-Spring/WHS Joint Meeting: Charlotte Convention Center, Charlotte, North Carolina, USA April 25–29, 2018
JO  - Wound Repair and Regeneration
JA  - Wound Rep Reg
VL  - 26
IS  - 1
SN  - 9781405153638
UR  - https://doi.org/10.1111/wrr.12622
DO  - doi:10.1111/wrr.12622
SP  - A1
EP  - A42
PY  - 2018
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - American Journal of Transplantation
VL  - 18
IS  - S4
SN  - 9781405153638
UR  - https://doi.org/10.1111/ajt.14917
DO  - doi:10.1111/ajt.14917
SP  - 245
EP  - 478
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts: Poster session
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 44
IS  - 3
SN  - 9781405153638
UR  - https://doi.org/10.1002/ana.410440342
DO  - doi:10.1002/ana.410440342
SP  - 441
EP  - 508
PY  - 1998
ER  - 

TY  - JOUR
TI  - SIOP 2013 Scientific Programme + Index
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 60
IS  - S3
SN  - 9781405153638
UR  - https://doi.org/10.1002/pbc.24719
DO  - doi:10.1002/pbc.24719
SP  - S1
EP  - S264
PY  - 2013
ER  - 

TY  - JOUR
TI  - Abstracts accepted for the VIIIth World Congress of the International Society for Artificial Organs and the IVth International Symposium on Blood Substitutes
JO  - Artificial Organs
VL  - 15
IS  - 4
SN  - 9781405153638
UR  - https://doi.org/10.1111/j.1525-1594.1991.tb00780.x
DO  - doi:10.1111/j.1525-1594.1991.tb00780.x
SP  - 270
EP  - 348
PY  - 1991
ER  - 

TY  - JOUR
TI  - Posters (Abstracts 289–2348)
JO  - Hepatology
JA  - Hepatology
VL  - 70
IS  - S1
SN  - 9781405153638
UR  - https://doi.org/10.1002/hep.30941
DO  - doi:10.1002/hep.30941
SP  - 188
EP  - 1382
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
JA  - BJOG: Int J Obstet Gy
VL  - 122
IS  - S2
SN  - 9781405153638
UR  - https://doi.org/10.1111/1471-0528.13389
DO  - doi:10.1111/1471-0528.13389
SP  - 18
EP  - 53
PY  - 2015
ER  - 

TY  - JOUR
TI  - Flash Posters
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 22
IS  - S1
SN  - 9781405153638
UR  - https://doi.org/10.1111/ene.12808
DO  - doi:10.1111/ene.12808
SP  - 484
EP  - 828
PY  - 2015
ER  - 

TY  - JOUR
TI  - ASGBI abstracts 2007 Poster presentations
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 94
IS  - S2
SN  - 9781405153638
UR  - https://doi.org/10.1002/bjs.5851
DO  - doi:10.1002/bjs.5851
SP  - 79
EP  - 198
PY  - 2007
AB  - Abstract The Annual Scientific Meeting of the Association of Surgeons of Great Britain and Ireland takes place this year at Manchester Central (18th - 20th April 2007), under the presidency of Professor Brian J Rowlands. To view all abstracts of poster presentations from this meeting, please click the pdf link on this page.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - HPB
VL  - 10
IS  - s2
SN  - 9781405153638
UR  - https://doi.org/10.1080/13651820801953544
DO  - doi:10.1080/13651820801953544
SP  - 28
EP  - 85
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidemiol Drug Saf
VL  - 22
IS  - s1
SN  - 9781405153638
UR  - https://doi.org/10.1002/pds.3512
DO  - doi:10.1002/pds.3512
SP  - 1
EP  - 521
PY  - 2013
ER  - 

TY  - JOUR
AU  - CONRAD, STEVEN A.
AU  - Bagley, Ann
AU  - Bagley, Barry
AU  - SCHAAP, ROBERT N.
TI  - Major Findings from the Clinical Trials of the Intravascular Oxygenator
JO  - Artificial Organs
VL  - 18
IS  - 11
SN  - 9781405153638
UR  - https://doi.org/10.1111/j.1525-1594.1994.tb03334.x
DO  - doi:10.1111/j.1525-1594.1994.tb03334.x
SP  - 846
EP  - 863
KW  - IVOX
KW  - Intravascular oxygenation
KW  - Clinical trials
KW  - Acute respiratory failure
PY  - 1994
AB  - Abstract: Major clinically relevant findings have been extracted and summarized from the database developed from the international multicenter clinical trials of the intravascular oxygenator (IVOX) as a means for augmenting the deficient blood gas transfer of patients in advanced acute respiratory failure (ARF). Between February 1990 and May 1993, a total of 164 IVOX devices were utilized in 160 clinical trial patients who were hypoxemic and/or hypercarbic while receiving closed system positive pressure mechanical ventilator support at or exceeding generally accepted minimum safe levels of intensity. The average rates of oxygen and carbon dioxide transfer into and out of circulating venous blood by means of the IVOX device varied from 40?70 ml/min. Evidence of patient benefit during IVOX utilization includes improvement in blood gas partial pressures associated with decreased intensity of mechanical ventilation, improved hemodynamics in patients with mechanical ventilator depressed cardiovascular function, and decreased indices of lung dysfunction. Clinically recognized IVOX?related complications or adverse events were reported in 24. 5% of the clinical trials patients. At necropsy examination of 68 clinical trials patients who died during or after I VOX utilization, forensic pathologists reported 4 cases in which IVOX utilization could have been a primary or contributing cause of death. Significant IVOX device mechanical and/or performance malfunction problems were recognized in 29 (17. 7%) of the IVOX devices utilized in clinical trials. IVOX clinical trials data collected and analyzed to date indicate IVOX utilization has a favorable risk/benefit ratio in patients in severe, acute, potentially reversible ARF.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Anaesthesia
JA  - Anaesthesia
VL  - 74
IS  - S2
SN  - 9781405153638
UR  - https://doi.org/10.1111/anae.14540
DO  - doi:10.1111/anae.14540
SP  - 9
EP  - 79
PY  - 2019
ER  - 

AU  - Wetzel, Gayle Delmonte
C7  - pp. 125-188
TI  - Medical Applications of Recombinant Proteins in Humans and Animals
SN  - 9783527257621
UR  - https://doi.org/10.1002/9783527620999.ch5d
DO  - doi:10.1002/9783527620999.ch5d
SP  - 125-188
KW  - recombinant
KW  - therapeutic
KW  - infarction
KW  - mortality
KW  - transcription
PY  - 2019
AB  - Summary The prelims comprise: Introduction Human Medical Applications of Recombinant Proteins Applications in Animals Concluding Remarks
ER  - 

AU  - Wetzel, Gayle Delmonte
C7  - pp. 125-188
TI  - Medical Applications of Recombinant Proteins in Humans and Animals
SN  - 9783527283156
UR  - https://doi.org/10.1002/9783527620869.ch5
DO  - doi:10.1002/9783527620869.ch5
SP  - 125-188
KW  - recombinant
KW  - therapeutic
KW  - infarction
KW  - mortality
KW  - transcription
PY  - 2019
AB  - Summary The prelims comprise: Introduction Human Medical Applications of Recombinant Proteins Applications in Animals Concluding Remarks
ER  - 
